neurophyxia.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home - |
| Description | About Management Advisors News update Literature Neuroprotection Contact Neuroprotection after oxygen shortage in the brain Neurophyxia is an innovative c |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 134.0.92.180 |
| Location | Netherlands |
Related Websites
| Site | Rank |
More to Explore
neurophyxia.com Valuation
|
US$534,432
Last updated: 2023-05-08 08:08:43
neurophyxia.com has Semrush global rank of 19,804,806. neurophyxia.com has an estimated worth of US$ 534,432, based on its estimated Ads revenue. neurophyxia.com receives approximately 61,666 unique visitors each day. Its web server is located in Netherlands, with IP address 134.0.92.180. According to SiteAdvisor, neurophyxia.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$534,432 |
| Daily Ads Revenue | US$494 |
| Monthly Ads Revenue | US$14,800 |
| Yearly Ads Revenue | US$177,596 |
| Daily Unique Visitors | 4,112 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| neurophyxia.com. | A | 3599 | IP: 134.0.92.180 |
| neurophyxia.com. | NS | 3600 | NS Record: ns1.cloudnet.services. |
| neurophyxia.com. | NS | 3600 | NS Record: ns2.cloudnet.services. |
| neurophyxia.com. | MX | 3600 | MX Record: 20 mailcluster01.ic-cloud.nl. |
| neurophyxia.com. | MX | 3600 | MX Record: 10 mail.neurophyxia.com. |
| neurophyxia.com. | TXT | 3600 | TXT Record: domain-verification:90270e71de73ddb9980d811a33bfcbc8fad58d5d |
| neurophyxia.com. | TXT | 3600 | TXT Record: domain-verification:8836d5840ce59fa7ec34edfd88596c27e7836e53 |
HtmlToTextCheckTime:2023-05-08 08:08:43
| About Management Advisors News update Literature Neuroprotection Contact Neuroprotection after oxygen shortage in the brain Neurophyxia is an innovative clinical drug development company developing novel drugs to reduce the deleterious effects of oxygen shortage in the brain. Our lead product 2-IB is currently in Phase II Clinical Trials for 3 indications: Stroke in adults Cardiac Arrest in adults Birth Asphyxia in newborns. Neurophyxia BV - Onderwijsboulevard 225 - 5223 DE - ’s- Hertogenbosch - The Netherlands. - Email: info@neurophyxia.com © Copyright 2023 |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 147 Content-Type: text/html; charset=UTF-8 Location: https://neurophyxia.com/ Server: Microsoft-IIS/10.0 Date: Fri, 29 Oct 2021 16:14:25 GMT HTTP/2 200 cache-control: no-cache pragma: no-cache content-length: 14726 content-type: text/html; charset=utf-8 expires: -1 date: Fri, 29 Oct 2021 16:14:25 GMT |
neurophyxia.com Whois Information
Domain Name: NEUROPHYXIA.COM Registry Domain ID: 1491206236_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.psi-usa.info Registrar URL: http://www.psi-usa.info Updated Date: 2021-08-01T13:46:17Z Creation Date: 2008-06-10T21:37:29Z Registry Expiry Date: 2023-06-10T21:37:29Z Registrar: PSI-USA, Inc. dba Domain Robot Registrar IANA ID: 151 Registrar Abuse Contact Email: domain-abuse@psi-usa.info Registrar Abuse Contact Phone: +49.94159559482 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.CLOUDNET.SERVICES Name Server: NS2.CLOUDNET.SERVICES DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T05:01:54Z <<< |